A Mesoporous Nanoenzyme Derived from Metal–Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy
Top Cited Papers
- 16 May 2019
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 31 (27) , e1901893
Abstract
Tumor hypoxia compromises the therapeutic efficiency of photodynamic therapy (PDT) as the local oxygen concentration plays an important role in the generation of cytotoxic singlet oxygen (1O2). Herein, a versatile mesoporous nanoenzyme (NE) derived from metal–organic frameworks (MOFs) is presented for in situ generation of endogenous O2 to enhance the PDT efficacy under bioimaging guidance. The mesoporous NE is constructed by first coating a manganese‐based MOFs with mesoporous silica, followed by a facile annealing process under the ambient atmosphere. After removing the mesoporous silica shell and post‐modifying with polydopamine and poly(ethylene glycol) for improving the biocompatibility, the obtained mesoporous NE is loaded with chlorin e6 (Ce6), a commonly used photosensitizer in PDT, with a high loading capacity. Upon the O2 generation through the catalytic reaction between the catalytic amount NE and the endogenous H2O2, the hypoxic tumor microenvironment is relieved. Thus, Ce6‐loaded NE serves as a H2O2‐activated oxygen supplier to increase the local O2 concentration for significantly enhanced antitumor PDT efficacy in vitro and in vivo. In addition, the NE also shows T2‐weighted magnetic resonance imaging ability for its in vivo tracking. This work presents an interesting biomedical use of MOF‐derived mesoporous NE as a multifunctional theranostic agent in cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (21571168, 31471268)
- National Research Foundation Singapore (NRF‐NRFI2018‐03)
This publication has 67 references indexed in Scilit:
- Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future DirectionsCancers, 2017
- Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor TherapyNano Letters, 2016
- Ratiometric Biosensor for Aggregation-Induced Emission-Guided Precise Photodynamic TherapyACS Nano, 2015
- Hypoxia Induced by Upconversion‐Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in TumorsAngewandte Chemie International Edition, 2015
- Nanoparticles in Photodynamic TherapyChemical Reviews, 2015
- Nanoscale Metal–Organic Framework for Highly Effective Photodynamic Therapy of Resistant Head and Neck CancerJournal of the American Chemical Society, 2014
- Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of NanoparticlesACS Nano, 2014
- Photodynamic therapy of cancer. Basic principles and applicationsClinical and Translational Oncology, 2008
- Cancer revoked: oncogenes as therapeutic targetsNature Reviews Cancer, 2003
- Photodynamic therapy: a clinical reality in the treatment of cancerThe Lancet Oncology, 2000